InvestorsHub Logo

surf1944

11/20/13 9:07 AM

#62 RE: surf1944 #59

7:08AM Myriad Genetics announces a research collaboration with BioMarin (BMRN) that will use Myriad's novel HRD (MYGN) 27.59 : Co announces a research collaboration with BioMarin (BRMN) that will use Myriad's novel HRD (Homologous Recombination Deficiency) test to identify tumor types that may be sensitive to BioMarin's investigational product candidate, BMN-673. Specific terms of the deal were not disclosed.